Comparable Enhanced Prothrombogenesis in Simple Central Obesity and Metabolic Syndrome
Table 1
Baseline characteristics of subjects according to groups.
Parameters
MS ()
COB ()
NC ()
value1 (MS versus NC)
value2 (COB versus NC)
value3 (MS versus COB)
Age (years)
48.7 ± 8.4
47.0 ± 8.5
46.2 ± 7.8
NS
NS
NS
bGender (% male/Female)
(36.8/63.2)
(28.0/72.0)
(34.4/65.6)
NS
NS
NS
bEthnicity (% Malay/Chinese/Indian/Bumiputera)
96.9/0.9/1.3/0.9
96.7/0.5/2.7/0.0
96.9/1.0/0.0/2.1
NS
NS
NS
bCurrent smoker (%)
12.1
8.8
14.3
NS
NS
NS
aBMI (kg/m2)
29.5 ± 4.1
28.9 ± 4.3
21.9 ± 2.5
NS
aWC (cm)
94.4 ± 8.8
93.0 ± 9.7
73.8 ± 7.7
NS
aSystolic BP (mmHg)
138.7 ± 22.4
125.4 ± 16.5
112.8 ± 10.0
aDiastolic BP (mmHg)
84.5 ± 12.8
78.4 ± 10.4
69.9 ± 8.4
aTC (mmol/L)
6.0 ± 1.1
5.6 ± 0.8
5.6 ± 1.0
NS
aTG (mmol/L)
2.3 ± 1.2
1.3 ± 0.4
1.0 ± 0.3
aHDL-c (mmol/L)
1.1 ± 0.3
1.4 ± 0.3
1.6 ± 0.4
aLDL-c (mmol/L)
3.8 ± 1.0
3.6 ± 0.7
3.5 ± 1.0
NS
NS
aFPG (mmol/L)
7.4 ± 3.3
5.1 ± 0.6
4.9 ± 0.5
Data are expressed as amean ± SD, or b percentage. ; NS: not significant; MS: metabolic syndrome; COB: simple central obesity; NC: normal controls; BMI: body mass index; WC: waist circumference; BP: blood pressure; TC: total cholesterol; TG: triglycerides; HDL-c: high density lipoprotein cholesterol; LDL-c: low density lipoprotein cholesterol; FPG: fasting plasma glucose.
